Today, the group is targeting sales growth of 10% to 15% at constant scope and in constant currencies (5% to 10% previously), and a 2.5 to 3 point increase in its operating margin on the proforma figure for 2009 (9% of revenue).

Sep 27 2010 --- Naturex, a global leader in specialty plant-based natural ingredients, has presented its development forecasts and strategy to the financial community.
Driven by strong and consistent growth on the natural ingredients market and by its new size since the beginning of the year following its acquisition of the Ingredients division of Natraceutical, the group's current business dynamic looks set to stay.
After an excellent first half (sales growth of close to 15% and a like-for-like improvement of over 2 points in its operating margin), Naturex's outlook for 2010 is positive. At constant scope and in constant currencies, sales were up 16.5% at the end of August.
As a result, Naturex is raising its financial objectives for 2010. Today, the group is targeting sales growth of 10% to 15% at constant scope and in constant currencies (5% to 10% previously), and a 2.5 to 3 point increase in its operating margin on the proforma figure for 2009 (9% of revenue).
Moreover, galvanized by the successful integration of the Ingredients division of Natraceutical in record time, Naturex is looking into new acquisition opportunities, the company reported.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Top Nutrition Trends 2027
Nutrition Insight










